Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 4 Seizures 3 Lennox Gastaut Syndrome 3 Epilepsies, Myoclonic 3 Anxiety Disorders 2 Tuberous Sclerosis 2 1 Tuberous Sclerosis 1 1 Spasms, Infantile 1 Prostatic Neoplasms 1 Parasomnias 1 Pain 1 Neoplasms 1 Nausea 1 Marijuana Abuse 1 Liver Cirrhosis 1 Glioblastoma 1 Epilepsy 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Cancer Pain 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Behavior 1

Interventions

Surveys and Questionnaires 2 Interviews as Topic 2 Transportation 1 Palliative Care 1 Methods 1 Exercise 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Behavior × Cannabidiol × 1 year × Clear all

NCT05864846 2026-04-27

EpiCom

Jazz Pharmaceuticals

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡